Soluble interleukin-2 receptor in sera of patients with Graves' disease

This publication has 21 references indexed in Scilit:

• The biology and clinical applications of interleukin 2
  Immunology Today, 1990
• SERUM SOLUBLE INTERLEUKIN 2 RECEPTOR IN HYPERTHYROID Graves'DISEASE AND EFFECT OF CARBIMAZOLE THERAPY
  Clinical Endocrinology, 1990
• The multichain interleukin 2 receptor. A target for immunotherapy in lymphoma, autoimmune disorders, and organ allografts [clinical reference]
  JAMA, 1990
• The role of interleukin 2 in autoimmunity
  Immunology Today, 1989
• Familial Occurrence of impaired interleukin-2 activity and increased peripheral blood B cells actively secreting immunoglobulins in systemic lupus erythematosus
  The American Journal of Medicine, 1989
• Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders
  Clinical Immunology and Immunopathology, 1989
• Elevated soluble interleukin‐2 receptor levels in the sera and synovial fluids of patients with rheumatoid arthritis
  Arthritis & Rheumatism, 1988
• Interleukin-2: Inception, Impact, and Implications
  Science, 1988
• SPECIFIC SUPPRESSOR T CELL FUNCTION IN A PATIENT WITH GRAVES' DISEASE AND HER HEALTHY IDENTICAL TWIN
  Clinical Endocrinology, 1984
• IDENTIFICATION OF SUBSETS OF PATIENTS WITH GRAVES’DISEASE BY CLUSTER ANALYSIS
  Clinical Endocrinology, 1983